Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1Neoplasms 1Meningeal Carcinomatosis 1Brain Neoplasms 1Advanced Breast Cancer 1

Interventions

Magnetic Resonance Spectroscopy 6Spinal Puncture 5Specimen Handling 5Methotrexate 3Trastuzumab 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2trastuzumab deruxtecan 1tipifarnib 1sacituzumab govitecan 1paclitaxel-Angiopep-2 conjugate 1merphos 1eribulin 1epothilone B 1Vinorelbine 1Sorafenib 1Referral and Consultation 1Radiation 1Probability 1Physical Examination 1Pemetrexed 1Immunotherapy, Adoptive 1Immunoenzyme Techniques 1Etoposide 1Cytarabine 1Craniospinal Irradiation 1Cisplatin 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningeal Carcinomatosis × Immunotherapy, Adoptive × Breast × Clear all
NCT03696030 2026-04-23

HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases

City of Hope Medical Center

Phase 1 Active not recruiting
24 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡